<DOC>
	<DOCNO>NCT00000180</DOCNO>
	<brief_summary>AIT-082 novel small molecule cross blood-brain barrier enhance nerve function increase level neurotrophic growth factor encourage nerve sprout brain . Preclinical study animal show AIT-082 improves memory age animal animal neurological deficit . This study double-blind placebo-controlled safety study design study whether AIT-082 may delay age-related mental decline . Eight healthy old volunteer two clinical site give single , weekly , rise dos AIT-082 placebo 5 week ; test side effect absorption ; underwent battery neuropsychological memory test , include word number recall test .</brief_summary>
	<brief_title>AIT-082 Phase 1B Study</brief_title>
	<detailed_description />
	<mesh_term>Memory Disorders</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2005</verification_date>
	<keyword>Memory</keyword>
	<keyword>Mild cognitive impairment</keyword>
	<keyword>Nerve growth factor</keyword>
</DOC>